Agnati LF, Cortelli P, Biagini G, Bjelke B, Fuxe K: Different classes of volume transmission signals exist in the central nervous system and are affected by metabolic signals, temperature gradients and pressure waves. Neuroreport. 1994, 6: 9-12.
Agnati LF, Guidolin D, Guescini M, Genedani S, Fuxe K: Understanding wiring and volume transmission. Brain Res Rev. 2010, 64: 137-159.
Fuxe K, Dahlstrom AB, Jonsson G, Marcellino D, Guescini M, Dam M, Manger P, Agnati L: The discovery of central monoamine neurons gave volume transmission to the wired brain. Prog Neurobiol. 2010, 90: 82-100.
Veening JG, de Jong T, Barendregt HP: Oxytocin-messages via the cerebrospinal fluid: behavioral effects; a review. Physiol Behav. 2010, 101: 193-210.
Frederickson RC, Geary LE: Endogenous opioid peptides: review of physiological, pharmacological and clinical aspects. Prog Neurobiol. 1982, 19: 19-69.
Sapolsky RM: Why zebra's don't get ulcers. 2004, Henry Holt & Company, New York, 3
Guillemin R, Ling N, Burgus R, Bloom F, Segal D: Characterization of the endorphins, novel hypothalamic and neurohypophysial peptides with opiate-like activity: evidence that they induce profound behavioral changes. Psychoneuroendocrinology. 1977, 2: 59-62.
Guillemin R, Ling N, Lazarus L, Burgus R, Minick S, Bloom F, Nicoll R, Siggins G, Segal D: The endorphins, novel peptides of brain and hypophysial origin, with opiate-like activity: biochemical and biologic studies. Ann N Y Acad Sci. 1977, 297: 131-157.
Bugnon C, Bloch B, Lenys D, Fellmann D: Infundibular neurons of the human hypothalamus simultaneously reactive with antisera against endorphins, ACTH, MSH and beta-LPH. Cell Tissue Res. 1979, 199: 177-196.
Bloch B, Bugnon C, Fellmann D, Lenys D, Gouget A: Neurons of the rat hypothalamus reactive with antisera against endorphins, ACTH, MSH and beta-LPH. Cell Tissue Res. 1979, 204: 1-15.
Nieuwenhuys R: Chemoarchitecture of the Brain. 1985, Springer, Berlin
Akil H, Watson SJ, Berger PA, Barchas JD: Endorphins, beta-LPH, and ACTH: biochemical, pharmacological and anatomical studies. Adv Biochem Psychopharmacol. 1978, 18: 125-139.
Akil H, Watson SJ, Young E, Lewis ME, Khachaturian H, Walker JM: Endogenous opioids: biology and function. Annu Rev Neurosci. 1984, 7: 223-255.
Bloom F, Segal D, Ling N, Guillemin R: Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science. 1976, 194: 630-632.
Davis BA, Fitzgerald ME, Brown JL, Amstalden KA, Coolen LM: Activation of POMC neurons during general arousal but not sexual behavior in male rats. Behav Neurosci. 2007, 121: 1012-1022.
Margules DL, Moisset B, Lewis MJ, Shibuya H, Pert CB: beta-Endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa). Science. 1978, 202: 988-991.
King MG, Kastin AJ, Olson RD, Coy DH: Systemic administration of Met-enkephalin, (D-Ala2)-Met-enkephalin, beta-endorphin, and (D-Ala2)-beta-endorphin: effects on eating, drinking and activity measures in rats. Pharmacol Biochem Behav. 1979, 11: 407-411.
Sanger DJ, McCarthy PS: Differential effects of morphine on food and water intake in food deprived and freely-feeding rats. Psychopharmacology (Berl). 1980, 72: 103-106.
Ieiri T, Chen HT, Meites J: Effects of morphine and naloxone on serum levels of luteinizing hormone and prolactin in prepubertal male and female rats. Neuroendocrinology. 1979, 29: 288-292.
Baizman ER, Cox BM: Endorphin in rat pituitary glands: its distribution within the gland, and age related changes in gland content in male and female rats. Life Sci. 1978, 22: 519-526.
Olson GA, Olson RD, Kastin AJ, Green MT, Roig-Smith R, Hill CW, Coy DH: Effects of an enkephalin analog on complex learning in the rhesus monkey. Pharmacol Biochem Behav. 1979, 11: 341-345.
Sandman CA, Kastin AJ: The influence of fragments of the LPH chains on learning, memory and attention in animals and man. Pharmacol Ther. 1981, 13: 39-60.
Stein L: Brain endorphins: possible mediators of pleasure and reward. Neurosci Res Program Bull. 1978, 16: 556-563.
Stein L, Belluzzi JD: Brain endorphins: possible role in reward and memory formation. Fed Proc. 1979, 38: 2468-2472.
Grevert P, Goldstein A: Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects. Proc Natl Acad Sci U S A. 1977, 74: 1291-1294.
Henderson RS: Endogenous opiates-a progress report. Anaesth Intensive Care. 1977, 5: 140-145.
Ray CD: On opiates, pain, and the nervous system. Neurosurgery. 1977, 1: 188-189.
Basbaum AI, Fields HL: Endogenous pain control mechanisms: review and hypothesis. Ann Neurol. 1978, 4: 451-462.
Fields HL, Basbaum AI: Brainstem control of spinal pain-transmission neurons. Annu Rev Physiol. 1978, 40: 217-248.
Almay BG, Johansson F, Von Knorring L, Terenius L, Wahlstrom A: Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes. Pain. 1978, 5: 153-162.
Terenius L: Significance of endorphins in endogenous antinociception. Adv Biochem Psychopharmacol. 1978, 18: 321-332.
Laubie M, Schmitt H, Vincent M, Remond G: Central cardiovascular effects of morphinomimetic peptides in dogs. Eur J Pharmacol. 1977, 46: 67-71.
Bolme P, Fuxe K, Agnati LF, Bradley R, Smythies J: Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats. Eur J Pharmacol. 1978, 48: 319-324.
Panksepp J, Vilberg T, Bean NJ, Coy DH, Kastin AJ: Reduction of distress vocalization in chicks by opiate-like peptides. Brain Res Bull. 1978, 3: 663-667.
Rossier J, French ED, Rivier C, Ling N, Guillemin R, Bloom FE: Foot-shock induced stress increases beta-endorphin levels in blood but not brain. Nature. 1977, 270: 618-620.
Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F: beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. Science. 1977, 197: 1367-1369.
Rossier J, Guillemin R, Bloom F: Foot shock induced stress decreases leu5-enkephalin immunoreactivity in rat hypothalamus. Eur J Pharmacol. 1978, 48: 465-466.
Abbruscato TJ, Thomas SA, Hruby VJ, Davis TP: Brain and spinal cord distribution of biphalin: correlation with opioid receptor density and mechanism of CNS entry. J Neurochem. 1997, 69: 1236-1245.
Skipor J, Thiery JC: The choroid plexus–cerebrospinal fluid system: undervaluated pathway of neuroendocrine signaling into the brain. Acta Neurobiol Exp (Wars). 2008, 68: 414-428.
Reiber H: Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci. 2003, 21: 79-96.
Stoodley MA, Jones NR, Brown CJ: Evidence for rapid fluid flow from the subarachnoid space into the spinal cord central canal in the rat. Brain Res. 1996, 707: 155-164.
Stoodley MA, Brown SA, Brown CJ, Jones NR: Arterial pulsation-dependent perivascular cerebrospinal fluid flow into the central canal in the sheep spinal cord. J Neurosurg. 1997, 86: 686-693.
Cifuentes M, Fernandez LP, Perez J, Perez-Figares JM, Rodriguez EM: Distribution of intraventricularly injected horseradish peroxidase in cerebrospinal fluid compartments of the rat spinal cord. Cell Tissue Res. 1992, 270: 485-494.
Banks WA, Kastin AJ: Saturable transport of peptides across the blood–brain barrier. Life Sci. 1987, 41: 1319-1338.
Banks WA, Kastin AJ, Ehrensing CA: Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1. J Neurosci Res. 1993, 35: 690-695.
King M, Su W, Chang A, Zuckerman A, Pasternak GW: Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nat Neurosci. 2001, 4: 268-274.
Nicholson C: Signals that go with the flow. Trends Neurosci. 1999, 22: 143-145.
Sewards TV, Sewards MA: Representations of motivational drives in mesial cortex, medial thalamus, hypothalamus and midbrain. Brain Res Bull. 2003, 61: 25-49.
Sewards TV, Sewards MA: Fear and power-dominance motivation: proposed contributions of peptide hormones present in cerebrospinal fluid and plasma. Neurosci Biobehav Rev. 2003, 27: 247-267.
Fuxe K, Rivera A, Jacobsen KX, Hoistad M, Leo G, Horvath TL, Staines W, De la Calle A, Agnati LF: Dynamics of volume transmission in the brain. Focus on catecholamine and opioid peptide communication and the role of uncoupling protein 2. J Neural Transm. 2005, 112: 65-76.
Fuxe K, Li XM, Bjelke B, Hedlund PB, Biagini G, Agnati LF: Possible mechanisms for the powerful actions of neuropeptides. Ann N Y Acad Sci. 1994, 739: 42-59.
Fuxe K, Dahlstrom A, Hoistad M, Marcellino D, Jansson A, Rivera A, Diaz-Cabiale Z, Jacobsen K, Tinner-Staines B, Hagman B, et al: From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: wiring and volume transmission. Brain Res Rev. 2007, 55: 17-54.
Bjelke B, Stromberg I, O'Connor WT, Andbjer B, Agnati LF, Fuxe K: Evidence for volume transmission in the dopamine denervated neostriatum of the rat after a unilateral nigral 6-OHDA microinjection. Studies with systemic D-amphetamine treatment. Brain Res. 1994, 662: 11-24.
Agnati LF, Leo G, Zanardi A, Genedani S, Rivera A, Fuxe K, Guidolin D: Volume transmission and wiring transmission from cellular to molecular networks: history and perspectives. Acta Physiol (Oxf). 2006, 187: 329-344.
Agnati LF, Fuxe K: Volume transmission as a key feature of information handling in the central nervous system possible new interpretative value of the Turing's B-type machine. Prog Brain Res. 2000, 125: 3-19.
Agnati LF, Bjelke B, Fuxe K: Volume versus wiring transmission in the brain: a new theoretical frame for neuropsychopharmacology. Med Res Rev. 1995, 15: 33-45.
Caraty A, Skinner DC: Gonadotropin-releasing hormone in third ventricular cerebrospinal fluid: endogenous distribution and exogenous uptake. Endocrinology. 2008, 149: 5227-5234.
Faulconbridge LF, Grill HJ, Kaplan JM: Distinct forebrain and caudal brainstem contributions to the neuropeptide Y mediation of ghrelin hyperphagia. Diabetes. 2005, 54: 1985-1993.
Flynn FW: Fourth ventricle bombesin injection suppresses ingestive behaviors in rats. Am J Physiol. 1989, 256: R590-R596.
Grill HJ, Carmody JS, Amanda Sadacca L, Williams DL, Kaplan JM: Attenuation of lipopolysaccharide anorexia by antagonism of caudal brain stem but not forebrain GLP-1-R. Am J Physiol. 2004, 287: R1190-R1193.
Ritter RC, Slusser PG, Stone S: Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science. 1981, 213: 451-452.
Skinner DC, Malpaux B: High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology. 1999, 140: 4399-4405.
Skinner DC, Malpaux B, Delaleu B, Caraty A: Luteinizing hormone (LH)-releasing hormone in third ventricular cerebrospinal fluid of the ewe: correlation with LH pulses and the LH surge. Endocrinology. 1995, 136: 3230-3237.
Tricoire H, Locatelli A, Chemineau P, Malpaux B: Melatonin enters the cerebrospinal fluid through the pineal recess. Endocrinology. 2002, 143: 84-90.
Tricoire H, Moller M, Chemineau P, Malpaux B: Origin of cerebrospinal fluid melatonin and possible function in the integration of photoperiod. Reprod Suppl. 2003, 61: 311-321.
Malpaux B, Daveau A, Maurice-Mandon F, Duarte G, Chemineau P: Evidence that melatonin acts in the premammillary hypothalamic area to control reproduction in the ewe: presence of binding sites and stimulation of luteinizing hormone secretion by in situ microimplant delivery. Endocrinology. 1998, 139: 1508-1516.
Knigge KM, Joseph SA: Anatomy of the opioid-systems of the brain. Can J Neurol Sci. 1984, 11: 14-23.
Bloom F, Battenberg E, Rossier J, Ling N, Guillemin R: Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proc Natl Acad Sci U S A. 1978, 75: 1591-1595.
Watson SJ, Akil H: alpha-MSH in rat brain: occurrence within and outside of beta-endorphin neurons. Brain Res. 1980, 182: 217-223.
Mezey E, Kiss JZ, Mueller GP, Eskay R, O'Donohue TL, Palkovits M: Distribution of the pro-opiomelanocortin derived peptides, adrenocorticotrope hormone, alpha-melanocyte-stimulating hormone and beta-endorphin (ACTH, alpha-MSH, beta-END) in the rat hypothalamus. Brain Res. 1985, 328: 341-347.
Tranchand-Bunel D, Delbende C, Guy J, Jegou S, Jenks BJ, Mocaer E, Pelletier G, Vaudry H: Pro-opiomelanocortin neuronal systems. Rev Neurol (Paris). 1987, 143: 471-489.
McGinty JF, Bloom FE: Double immunostaining reveals distinctions among opioid peptidergic neurons in the medial basal hypothalamus. Brain Res. 1983, 278: 145-153.
Ibata Y, Kawakami F, Okamura H, Obata-Tsuto HL, Morimoto N, Zimmerman EA: Light and electron microscopic immunocytochemistry of beta-endorphin/beta-LPH-like immunoreactive neurons in the arcuate nucleus and surrounding areas of the rat hypothalamus. Brain Res. 1985, 341: 233-242.
Buma P, Veening J, Hafmans T, Joosten H, Nieuwenhuys R: Ultrastructure of the periaqueductal grey matter of the rat: an electron microscopical and horseradish peroxidase study. J Comp Neurol. 1992, 319: 519-535.
Buma P, Veening J, Nieuwenhuys R: Ultrastructural Characterization of Adrenocorticotrope Hormone (ACTH) Immunoreactive Fibres in the Mesencephalic Central Grey Substance of the Rat. Eur J Neurosci. 1989, 1: 659-672.
Finley JC, Lindstrom P, Petrusz P: Immunocytochemical localization of beta-endorphin-containing neurons in the rat brain. Neuroendocrinology. 1981, 33: 28-42.
Calle M: Integrative Physiology and Communication in the Amphibian brain. 2006, Radboud University, Nijmegen, Depts of Cellular animal Physiology/Computational Sciences.
Calle M, Claassen IE, Veening JG, Kozicz T, Roubos EW, Barendregt HP: Opioid peptides, CRF, and urocortin in cerebrospinal fluid-contacting neurons in Xenopus laevis. Ann N Y Acad Sci. 2005, 1040: 249-252.
Rodriguez EM, Blazquez JL, Guerra M: The design of barriers in the hypothalamus allows the median eminence and the arcuate nucleus to enjoy private milieus: the former opens to the portal blood and the latter to the cerebrospinal fluid. Peptides. 2010, 31: 757-776.
Chen YY, Pelletier G: Demonstration of contacts between proopiomelanocortin neurons in the rat hypothalamus. Neurosci Lett. 1983, 43: 271-276.
Pelletier G, Leclerc R, Saavedra JM, Brownstein MJ, Vaudry H, Ferland L, Labrie F: Distribution of beta-lipotropin (beta-LPH), adrenocorticotropin (ACTH) and alpha-melanocyte-stimulating hormone (alpha-MSH) in the rat brain. I. Origin of the extrahypothalamic fibers. Brain Res. 1980, 192: 433-440.
Barnea A, Cho G, Pilotte NS, Porter JC: Regional differences in the molecular weight profiles of corticotropin and alpha-melanotropin the hypothalamus. Endocrinology. 1981, 108: 150-156.
Dores RM, Khachaturian H, Watson SJ, Akil H: Localization of neurons containing pro-opiomelanocortin-related peptides in the hypothalamus and midbrain of the lizard, Anolis carolinensis: evidence for region-specific processing of beta-endorphin. Brain Res. 1984, 324: 384-389.
Swanson LW: Biochemical switching in hypothalamic circuits mediating responses to stress. Prog Brain Res. 1991, 87: 181-200.
Swanson LW, Sawchenko PE, Lind RW: Regulation of multiple peptides in CRF parvocellular neurosecretory neurons: implications for the stress response. Prog Brain Res. 1986, 68: 169-190.
Swanson LW, Simmons DM: Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J Comp Neurol. 1989, 285: 413-435.
Mulders WH, Meek J, Hafmans TG, Cools AR: Plasticity in the stress-regulating circuit: decreased input from the bed nucleus of the stria terminalis to the hypothalamic paraventricular nucleus in Wistar rats following adrenalectomy. Eur J Neurosci. 1997, 9: 2462-2471.
Van der Horst VG, Holstege G: Sensory and motor components of reproductive behavior: pathways and plasticity. Behav Brain Res. 1998, 92: 157-167.
Douglas AJ, Bicknell RJ, Leng G, Russell JA, Meddle SL: Beta-endorphin cells in the arcuate nucleus: projections to the supraoptic nucleus and changes in expression during pregnancy and parturition. J Neuroendocrinol. 2002, 14: 768-777.
Watson SJ, Richard CW, Barchas JD: Adrenocorticotropin in rat brain: immunocytochemical localization in cells and axons. Science. 1978, 200: 1180-1182.
Watson SJ, Barchas JD, Li CH: beta-Lipotropin: localization of cells and axons in rat brain by immunocytochemistry. Proc Natl Acad Sci U S A. 1977, 74: 5155-5158.
Knigge KM, Joseph SA, Nocton J: Topography of the ACTH-immunoreactive neurons in the basal hypothalamus of the rat brain. Brain Res. 1981, 216: 333-341.
Romagnano MA, Joseph SA: Immunocytochemical localization of ACTH1-39 in the brainstem of the rat. Brain Res. 1983, 276: 1-16.
Sawchenko PE, Swanson LW, Joseph SA: The distribution and cells of origin of ACTH(1–39)-stained varicosities in the paraventricular and supraoptic nuclei. Brain Res. 1982, 232: 365-374.
Joseph SA: Immunoreactive adrenocorticotropin in rat brain: a neuroanatomical study using antiserum generated against synthetic ACTH. Am J Anat. 1980, 158: 533-548.
Yoshida M, Taniguchi Y: Projection of pro-opiomelanocortin neurons from the rat arcuate nucleus to the midbrain central gray as demonstrated by double staining with retrograde labeling and immunohistochemistry. Arch Histol Cytol. 1988, 51: 175-183.
Pretel S, Piekut DT: ACTH and enkephalin axonal input to paraventricular neurons containing c-fos-like immunoreactivity. Synapse. 1991, 8: 100-106.
Hornby PJ, Piekut DT: Anatomical evidence for interaction of ACTH1-39 immunostained fibers and hypothalamic paraventricular neurons that project to the dorsal vagal complex. Histochemistry. 1988, 90: 201-206.
Piekut DT: Interactions of immunostained ACTH1-39 fibers and CRF neurons in the paraventricular nucleus of rat hypothalamus: application of avidin-glucose oxidase to dual immunostaining procedures. J Histochem Cytochem. 1987, 35: 261-265.
Piekut DT: Relationship of ACTH1-39-immunostained fibers and magnocellular neurons in the paraventricular nucleus of rat hypothalamus. Peptides. 1985, 6: 883-890.
Kawano H, Masuko S: beta-endorphin-, adrenocorticotrophic hormone- and neuropeptide Y-containing projection fibers from the arcuate hypothalamic nucleus make synaptic contacts on to nucleus preopticus medianus neurons projecting to the paraventricular hypothalamic nucleus in the rat. Neuroscience. 2000, 98: 555-565.
Joseph SA, Pilcher WH, Knigge KM: Anatomy of the corticotropin-releasing factor and opiomelanocortin systems of the brain. Fed Proc. 1985, 44: 100-107.
Wilcox JN, Roberts JL, Chronwall BM, Bishop JF, Odonohue T: Localization of Proopiomelanocortin Messenger-Rna in Functional Subsets of Neurons Defined by Their Axonal Projections. J Neurosci Res. 1986, 16: 89-96.
Veening JG, Buma P, ter Horst GJ, Roeling TAP, Luiten PGM, Nieuwenhuys R: Hypothalamic projections to the PAG in the rat: topographical, immunoelectronmicroscopical and functional aspects. The Midbrain Periaqueductal Gray Matter. Edited by: Depaulis A, Bandler R. 1991, Plenum Press, New York, 387-415.
Joseph SA, Pilcher WH, Bennett-Clarke C: Immunocytochemical localization of ACTH perikarya in nucleus tractus solitarius: evidence for a second opiocortin neuronal system. Neurosci Lett. 1983, 38: 221-225.
Joseph SA, Michael GJ: Efferent ACTH-IR opiocortin projections from nucleus tractus solitarius: a hypothalamic deafferentation study. Peptides. 1988, 9: 193-201.
Tsou K, Khachaturian H, Akil H, Watson SJ: Immunocytochemical localization of pro-opiomelanocortin-derived peptides in the adult rat spinal cord. Brain Res. 1986, 378: 28-35.
Bloom F, Battenberg E, Rossier J, Ling N, Leppaluoto J, Vargo TM, Guillemin R: Endorphins are located in the intermediate and anterior lobes of the pituitary gland, not in the neurohypophysis. Life Sci. 1977, 20: 43-47.
Khachaturian H, Lewis ME, Schafer MK, Watson SJ: Anatomy of the CNS opioid systems. Trends Neurosci. 1985, 8: 111-119.
Rossier J, Vargo TM, Minick S, Ling N, Bloom FE, Guillemin R: Regional dissociation of beta-endorphin and enkephalin contents in rat brain and pituitary. Proc Natl Acad Sci U S A. 1977, 74: 5162-5165.
de Kloet ER, Palkovits M, Mezey E: Opiocortin peptides: localization, source and avenues of transport. Pharmacol Ther. 1981, 12: 321-351.
Howe A: The mammalian pars intermedia: a review of its structure and function. J Endocrinol. 1973, 59: 385-409.
O'Donohue TL, Dorsa DM: The opiomelanotropinergic neuronal and endocrine systems. Peptides. 1982, 3: 353-395.
Silman RE, Chard T, Landon J, Lowry PJ, Smith I, Young IM: ACTH and MSH peptides in the human adult and fetal pituitary gland. Front Horm Res. 1977, 4: 179-187.
Houghten RA, Swann RW, Li CH: beta-Endorphin: stability, clearance behavior, and entry into the central nervous system after intravenous injection of the tritiated peptide in rats and rabbits. Proc Natl Acad Sci U S A. 1980, 77: 4588-4591.
Barna I, Sweep CG, Veldhuis HD, Wiegant VM, De Wied D: Effects of pituitary beta-endorphin secretagogues on the concentration of beta-endorphin in rat cerebrospinal fluid: evidence for a role of vasopressin in the regulation of brain beta-endorphin release. Neuroendocrinology. 1990, 51: 104-110.
De Riu PL, Petruzzi V, Caria MA, Mameli O, Casu AR, Nuvoli S, Spanu A, Madeddu G: Beta-endorphin and cortisol levels in plasma and CSF following acute experimental spinal traumas. Physiol Behav. 1997, 62: 1-5.
Guo ZM, Liu CT, Peters CJ: Possible involvement of endogenous beta-endorphin in the pathophysiological mechanisms of Pichinde virus-infected guinea pigs. Proc Soc Exp Biol Med. 1992, 200: 343-348.
Yamamoto T, Sako N, Maeda S: Effects of taste stimulation on beta-endorphin levels in rat cerebrospinal fluid and plasma. Physiol Behav. 2000, 69: 345-350.
Barna I, Sweep CG, Veldhuis HD, Wiegant VM: Differential effects of cisterna magna cannulation on beta-endorphin levels in rat plasma and cerebrospinal fluid. Acta Endocrinol (Copenh). 1988, 117: 517-524.
Nakao K, Nakai Y, Oki S, Matsubara S, Konishi T, Nishitani H, Imura H: Immunoreactive beta-endorphin in human cerebrospinal fluid. J Clin Endocrinol Metab. 1980, 50: 230-233.
Facchinetti F, Petraglia F, Nappi G, Martignoni E, Antoni G, Parrini D, Genazzani AR: Different patterns of central and peripheral beta EP, beta LPH and ACTH throughout life. Peptides. 1983, 4: 469-474.
Nakao K, Nakai Y, Jingami H, Oki S, Fukata J, Imura H: Substantial rise of plasma beta-endorphin levels after insulin-induced hypoglycemia in human subjects. J Clin Endocrinol Metab. 1979, 49: 838-841.
Nakao K, Nakai Y, Oki S, Horii K, Imura H: Presence of immunoreactive beta-endorphin in normal human plasma: a concomitant release of beta-endorphin with adrenocorticotropin after metyrapone administration. J Clin Invest. 1978, 62: 1395-1398.
Nappi G, Facchinetti F, Bono G, Petraglia F, Sinforiani E, Genazzani AR: CSF and plasma levels of pro-opiomelanocortin-related peptides in reversible ischaemic attacks and strokes. J Neurol Neurosurg Psychiatry. 1986, 49: 17-21.
Brunani A, Invitti C, Dubini A, Piccoletti R, Bendinelli P, Maroni P, Pezzoli G, Ramella G, Calogero A, Cavagnini F: Cerebrospinal fluid and plasma concentrations of SRIH, beta-endorphin, CRH, NPY and GHRH in obese and normal weight subjects. Int J Obes Relat Metab Disord. 1995, 19: 17-21.
Oki S, Nakai Y, Nakao K, Imura H: Plasma beta-endorphin responses to somatostatin, thyrotropin-releasing hormone, or vasopressin in Nelson's syndrome. J Clin Endocrinol Metab. 1980, 50: 194-197.
Steinbrook RA, Carr DB, Datta S, Naulty JS, Lee C, Fisher J: Dissociation of plasma and cerebrospinal fluid beta-endorphin-like immunoactivity levels during pregnancy and parturition. Anesth Analg. 1982, 61: 893-897.
Radzikowska B, Szczudlik A, Lypka A: Beta-endorphin levels in the blood and cerebrospinal fluid in humans. Neurol Neurochir Pol. 1985, 19: 281-285.
Adams ML, Morris DL, Brase DA, Dewey WL: Stereoselective effect of morphine on antinociception and endogenous opioid peptide levels in plasma but not cerebrospinal fluid of dogs. Life Sci. 1991, 48: 917-924.
Matejec R, Ruwoldt R, Bodeker RH, Hempelmann G, Teschemacher H: Release of beta-endorphin immunoreactive material under perioperative conditions into blood or cerebrospinal fluid: significance for postoperative pain?. Anesth Analg. 2003, 96: 481-486. table of contents
Spaziante R, Merola B, Colao A, Gargiulo G, Cafiero T, Irace C, Rossi E, Oliver C, Lombardi G, Mazzarella B, et al: Beta-endorphin concentrations both in plasma and in cerebrospinal fluid in response to acute painful stimuli. J Neurosurg Sci. 1990, 34: 99-106.
Spinazzola F, Barletta C, Demartino G, Martini F, Natili S, Noto P, Ferri F, Tossini G, Visco G: Beta-endorphins ACTH and cortisol in CSF and plasma of HIV infected patients. Riv Eur Sci Med Farmacol. 1995, 17: 161-165.
Barreca T, Siani C, Franceschini R, Francaviglia N, Messina V, Perria C, Rolandi E: Diurnal beta-endorphin changes in human cerebrospinal fluid. Life Sci. 1986, 38: 2263-2267.
Hamel E: CSF-endorphines in acute and chronic brain lesions. Neurosurg Rev. 1988, 11: 193-199.
Lopez JA, Peran F, Altuzarra A, Garrido F, Arjona V: Correlation between plasmatic and CSF beta-endorphin levels. Neurol Res. 1984, 6: 118-120.
Facchinetti F, Petraglia F, Sances G, Garuti C, Tosca P, Nappi G, Genazzani AR: Dissociation between CSF and plasma B-endorphin in major depressive disorders: evidence for a different regulation. J Endocrinol Invest. 1986, 9: 11-14.
Facchinetti F, Sforza G, Amidei M, Cozza C, Petraglia F, Montanari C, Genazzani AR: Central and peripheral beta-endorphin response to transcutaneous electrical nerve stimulation. NIDA Res Monogr. 1986, 75: 555-558.
Morales AB, Vives F, Ros I, Mora F: Plasma and CSF levels of immunoreactive beta-endorphin in algic peaks of patients with herniated intervertebral discs. Rev Esp Fisiol. 1988, 44: 21-25.
Smith R, Owens PC, Lovelock M, Chan EC, Falconer J: Acute hemorrhagic stress in conscious sheep elevates immunoreactive beta-endorphin in plasma but not in cerebrospinal fluid. Endocrinology. 1986, 118: 2572-2576.
Burbach JP, De Hoop MJ, Schmale H, Richter D, De Kloet ER, Ten Haaf JA, De Wied D: Differential responses to osmotic stress of vasopressin-neurophysin mRNA in hypothalamic nuclei. Neuroendocrinology. 1984, 39: 582-584.
Burbach JP, Loeber JG, Verhoef J, de Kloet ER, van Ree JM, de Wied D: Schizophrenia and degradation of endorphins in cerebrospinal fluid. Lancet. 1979, 2: 480-481.
Ambach G, Palkovits M, Szentagothai J: Blood supply of the rat hypothalamus. IV. Retrochiasmatic area, median eminence, arcuate nucleus. Acta Morphol Acad Sci Hung. 1976, 24: 93-119.
Oliver C, Mical RS, Porter JC: Hypothalamic-pituitary vasculature: evidence for retrograde blood flow in the pituitary stalk. Endocrinology. 1977, 101: 598-604.
Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A, Meier PJ: Organic anion-transporting polypeptides mediate transport of opioid peptides across blood–brain barrier. J Pharmacol Exp Ther. 2000, 294: 73-79.
Bach FW, Yaksh TL: Release into ventriculo-cisternal perfusate of beta-endorphin- and Met-enkephalin-immunoreactivity: effects of electrical stimulation in the arcuate nucleus and periaqueductal gray of the rat. Brain Res. 1995, 690: 167-176.
Bach FW, Yaksh TL: Release of beta-endorphin immunoreactivity from brain by activation of a hypothalamic N-methyl-D-aspartate receptor. Neuroscience. 1995, 65: 775-783.
MacMillan SJ, Mark MA, Duggan AW: The release of beta-endorphin and the neuropeptide-receptor mismatch in the brain. Brain Res. 1998, 794: 127-136.
Dias RD, Perry ML, Carrasco MA, Izquierdo I: Effect of electroconvulsive shock on beta-endorphin immunoreactivity of rat brain, pituitary gland, and plasma. Behav Neural Biol. 1981, 32: 265-268.
Kosten TR, Kreek MJ, Swift C, Carney MK, Ferdinands L: Beta endorphin levels in CSF during methadone maintenance. Life Sci. 1987, 41: 1071-1076.
Izquierdo I, Netto CA: Role of beta-endorphin in behavioral regulation. Ann N Y Acad Sci. 1985, 444: 162-177.
Wan RQ, Wiegant VM, de Jong W, de Wied D: Alterations of beta-endorphin-like immunoreactivity in CSF following behavioral training using a passive avoidance procedure. Psychoneuroendocrinology. 1996, 21: 503-513.
Sweep CG, Boomkamp MD, Barna I, Logtenberg AW, Wiegant VM: Vasopressin enhances the clearance of beta-endorphin immunoreactivity from rat cerebrospinal fluid. Acta Endocrinol (Copenh). 1990, 122: 191-200.
Sweep CGJ, Barna I, Wiegant VM: Dual effects of vasopressin on the concentration of beta-endorphin immunoreactivity in rat cerebrospinal fluid. Adv Biosci. 1989, 75: 371-374.
Banks WA: The CNS as a target for peptides and peptide-based drugs. Expert Opin Drug Deliv. 2006, 3: 707-712.
Banks WA: Are the extracellular [correction of extracelluar] pathways a conduit for the delivery of therapeutics to the brain?. Curr Pharm Des. 2004, 10: 1365-1370.
Nieuwenhuys R, Veening JG, van Domburg P: Core and paracores; some new chemoarchitectural entities in the mammalian neuraxis. Acta Morphol Neer Sc. 1988, 26: 131-163.
Veening JG, Barendregt HP: The regulation of brain states by neuroactive substances distributed via the cerebrospinal fluid; a review. Cerebrospinal Fluid Res. 2010, 7: 1-
Bjelke B, England R, Nicholson C, Rice ME, Lindberg J, Zoli M, Agnati LF, Fuxe K: Long distance pathways of diffusion for dextran along fibre bundles in brain. Relevance for volume transmission. Neuroreport. 1995, 6: 1005-1009.
Agnati LF, Fuxe K, Zoli M, Ozini I, Toffano G, Ferraguti F: A correlation analysis of the regional distribution of central enkephalin and beta-endorphin immunoreactive terminals and of opiate receptors in adult and old male rats. Evidence for the existence of two main types of communication in the central nervous system: the volume transmission and the wiring transmission. Acta Physiol Scand. 1986, 128: 201-207.
Bjelke B, Fuxe K: Intraventricular beta-endorphin accumulates in DARPP-32 immunoreactive tanycytes. Neuroreport. 1993, 5: 265-268.
Fuxe K, Tinner B, Bjelke B, Agnati LF, Verhofstad A, Steinbusch HG, Goldstein M, Hersh L, Kalia M: Monoaminergic and Peptidergic Innervation of the Intermedio-Lateral Horn of the Spinal Cord. Eur J Neurosci. 1990, 2: 451-460.
Hoistad M, Samskog J, Jacobsen KX, Olsson A, Hansson HA, Brodin E, Fuxe K: Detection of beta-endorphin in the cerebrospinal fluid after intrastriatal microinjection into the rat brain. Brain Res. 2005, 1041: 167-180.
Agnati LF, Fuxe K, Locatelli V, Benfenati F, Zini I, Panerai AE, El Etreby MF, Hokfelt T: Neuroanatomical methods for the quantitative evaluation of coexistence of transmitters in nerve cells. Analysis of the ACTH- and beta-endorphin immunoreactive nerve cell bodies of the mediobasal hypothalamus of the rat. J Neurosci Methods. 1982, 5: 203-214.
Agnati LF, Zoli M, Stromberg I, Fuxe K: Intercellular communication in the brain: wiring versus volume transmission. Neuroscience. 1995, 69: 711-726.
Fuxe K, Agnati LF, Zoli M, Bjelke B, Zini I: Some aspects of the communicational and computational organization of the brain. Acta Physiol Scand. 1989, 135: 203-216.
Rodriguez EM, Blazquez JL, Pastor FE, Pelaez B, Pena P, Peruzzo B, Amat P: Hypothalamic tanycytes: a key component of brain-endocrine interaction. Int Rev Cytol. 2005, 247: 89-164.
Broadwell RD, Brightman MW: Entry of Peroxidase into Neurons of Central and Peripheral Nervous Systems from Extracerebral and Cerebral Blood. J Comp Neurol. 1976, 166: 257-283.
Millhouse OE: A Golgi study of third ventricle tanycytes in the adult rodent brain. Z Zellforsch Mikrosk Anat. 1971, 121: 1-13.
Peruzzo B, Pastor FE, Blazquez JL, Schobitz K, Pelaez B, Amat P, Rodriguez EM: A second look at the barriers of the medial basal hypothalamus. Exp Brain Res. 2000, 132: 10-26.
Rethelyi M: Diffusional Barrier around the Hypothalamic Arcuate Nucleus in the Rat. Brain Res. 1984, 307: 355-358.
Vandenpol AN, Cassidy JR: The Hypothalamic Arcuate Nucleus of Rat - a Quantitative Golgi Analysis. J Comp Neurol. 1982, 204: 65-98.
Leslie FM, Chen Y, Winzer-Serhan UH: Opioid receptor and peptide mRNA expression in proliferative zones of fetal rat central nervous system. Can J Physiol Pharmacol. 1998, 76: 284-293.
Burbach JP: Action of proteolytic enzymes on lipotropins and endorphins: biosynthesis, biotransformation and fate. Pharmacol Ther. 1984, 24: 321-354.
Yamamoto M, Kubota Y, Matsuura M, Homma JY: Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP). Kansenshogaku Zasshi. 1986, 60: 1178-1183.
Akil H, Richardson DE, Barchas JD, Li CH: Appearance of beta-endorphin-like immunoreactivity in human ventricular cerebrospinal fluid upon analgesic electrical stimulation. Proc Natl Acad Sci U S A. 1978, 75: 5170-5172.
Young RF, Bach FW, Van Norman AS, Yaksh TL: Release of beta-endorphin and methionine-enkephalin into cerebrospinal fluid during deep brain stimulation for chronic pain. Effects of stimulation locus and site of sampling. J Neurosurg. 1993, 79: 816-825.
Izquierdo I, Netto CA, Carrasco MA, Dias RD, Volkmer N: The course of the decrease of hypothalamic beta-endorphin induced by training, and the development of the effect of beta-endorphin on the retrieval of inhibitory avoidance in rats. Braz J Med Biol Res. 1985, 18: 391-395.
Ableitner A, Schulz R: Neuroanatomical sites mediating the central actions of beta-endorphin as mapped by changes in glucose utilization: involvement of mu opioid receptors. J Pharmacol Exp Ther. 1992, 262: 415-423.
Sagen J, Wang H, Pappas GD: Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model. Pain. 1990, 42: 69-79.
Siegan JB, Sagen J: Attenuation of formalin pain responses in the rat by adrenal medullary transplants in the spinal subarachnoid space. Pain. 1997, 70: 279-285.
Yadid G, Zangen A, Herzberg U, Nakash R, Sagen J: Alterations in endogenous brain beta-endorphin release by adrenal medullary transplants in the spinal cord. Neuropsychopharmacology. 2000, 23: 709-716.
Finegold AA, Mannes AJ, Iadarola MJ: A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Hum Gene Ther. 1999, 10: 1251-1257.
Leak RK, Moore RY: Innervation of ventricular and periventricular brain compartments. Brain Res. 2012, 1463: 51-62.
Zhang LC, Zeng YM, Ting J, Cao JP, Wang MS: The distributions and signaling directions of the cerebrospinal fluid contacting neurons in the parenchyma of a rat brain. Brain Res. 2003, 989: 1-8.
Vigh B, Silva MJ, Manzano E, Frank CL, Vincze C, Czirok SJ, Szabo A, Lukats A, Szel A: The system of cerebrospinal fluid-contacting neurons. Its supposed role in the nonsynaptic signal transmission of the brain. Histol Histopathol. 2004, 19: 607-628.
Sabatier N, Caquineau C, Dayanithi G, Bull P, Douglas AJ, Guan XMM, Jiang M, Van der Ploeg L, Leng G: alpha-melanocyte-stimulating hormone stimulates oxytocin release from the dendrites of hypothalamic neurons while inhibiting oxytocin release from their terminals in the neurohypophysis. J Neurosci. 2003, 23: 10351-10358.
Sabatier N, Caquineau C, Douglas AJ, Leng G: Oxytocin released from magnocellular dendrites - A potential modulator of alpha-melanocyte-stimulating hormone behavioral actions?. Melanocortin System. 2003, 994: 218-224.
Sabatier N, Leng G: Presynaptic actions of endocannabinoids mediate alpha-MSH-induced inhibition of oxytocin cells. Am J Physiol-Reg I. 2006, 290: R577-R584.
Brunton PJ, Sabatier N, Leng G, Russell JA: Suppressed oxytocin neuron responses to immune challenge in late pregnant rats: a role for endogenous opioids. Eur J Neurosci. 2006, 23: 1241-1247.
Landgraf R, Neumann ID: Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol. 2004, 25: 150-176.
Leng G, Ludwig M: Jacques Benoit Lecture. Information processing in the hypothalamus: peptides and analogue computation. J Neuroendocrinol. 2006, 18: 379-392.
Hentges ST: Synaptic regulation of proopiomelanocortin neurons can occur distal to the arcuate nucleus. J Neurophysiol. 2007, 97: 3298-3304.
Bakkali-Kassemi L, El Ouezzani S, Magoul R, Merroun I, Lopez-Jurado M, Errami M: Effects of cannabinoids on neuropeptide Y and beta-endorphin expression in the rat hypothalamic arcuate nucleus. Br J Nutr. 2011, 105: 654-660.
Krieger DT, Liotta AS, Hauser H, Brownstein MJ: Effect of stress, adrenocorticotropin or corticosteroid treatment, adrenalectomy, or hypophysectomy on hypothalamic immunoreactive adrenocorticotropin concentrations. Endocrinology. 1979, 105: 737-742.
Berrettini WH, Nurnberger JI, Chan JS, Chrousos GP, Gaspar L, Gold PW, Seidah NG, Simmons-Alling S, Goldin LR, Chretien M, et al: Pro-opiomelanocortin-related peptides in cerebrospinal fluid: a study of manic-depressive disorder. Psychiatry Res. 1985, 16: 287-302.
Tsigos C, Crosby SR, Gibson S, Young RJ, White A: Proopiomelanocortin is the predominant adrenocorticotropin-related peptide in human cerebrospinal fluid. J Clin Endocrinol Metab. 1993, 76: 620-624.
Pritchard LE, Oliver RL, McLoughlin JD, Birtles S, Lawrence CB, Turnbull AV, White A: Proopiomelanocortin-derived peptides in rat cerebrospinal fluid and hypothalamic extracts: evidence that secretion is regulated with respect to energy balance. Endocrinology. 2003, 144: 760-766.
Pritchard LE, Turnbull AV, White A: Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol. 2002, 172: 411-421.
Pritchard LE, White A: Neuropeptide processing and its impact on melanocortin pathways. Endocrinology. 2007, 148: 4201-4207.
Gessa GL, Fratta W, Melis M, Bertolini A, Ferrari W: Hypothalamic ACTH and MSH levels increase in morphine tolerance and decrease after morphine withdrawal. Eur J Pharmacol. 1983, 95: 143-144.
Vergoni AV, Poggioli R, Facchinetti F, Bazzani C, Marrama D, Bertolini A: Tolerance develops to the behavioural effects of ACTH-(1–24) during continuous i.c.v. infusion in rats, and is associated with increased hypothalamic levels of beta-endorphin. Neuropeptides. 1989, 14: 93-98.
Roberts AC, Martensz ND, Hastings MH, Herbert J: The effects of castration, testosterone replacement and photoperiod upon hypothalamic beta-endorphin levels in the male Syrian hamster. Neuroscience. 1987, 23: 1075-1082.
Zhang X, Leng G, Feng J: Coherent peptide-mediated activity in a neuronal network controlled by subcellular signaling pathway: experiments and modeling. J Biotechnol. 2010, 149: 215-225.
Chronwall BM: Anatomy and Physiology of the Neuro-Endocrine Arcuate Nucleus. Peptides. 1985, 6: 1-11.
Jirikowski GF, Merchenthaler I, Rieger GE, Stumpf WE: Estradiol target sites immunoreactive for beta-endorphin in the arcuate nucleus of rat and mouse hypothalamus. Neurosci Lett. 1986, 65: 121-126.
Miller MM, Tousignant P, Yang U, Pedvis S, Billiar RB: Effects of age and long-term ovariectomy on the estrogen-receptor containing subpopulations of beta-endorphin-immunoreactive neurons in the arcuate nucleus of female C57BL/6J mice. Neuroendocrinology. 1995, 61: 542-551.
Morrell JI, McGinty JF, Pfaff DW: A subset of beta-endorphin- or dynorphin-containing neurons in the medial basal hypothalamus accumulates estradiol. Neuroendocrinology. 1985, 41: 417-426.
Thornton JE, Loose MD, Kelly MJ, Ronnekleiv OK: Effects of estrogen on the number of neurons expressing beta-endorphin in the medial basal hypothalamus of the female guinea pig. J Comp Neurol. 1994, 341: 68-77.
Simerly RB, Mccall LD, Watson SJ: Distribution of Opioid-Peptides in the Preoptic Region - Immunohistochemical Evidence for a Steroid-Sensitive Enkephalin Sexual Dimorphism. J Comp Neurol. 1988, 276: 442-459.
Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ: Anatomy of CNS opioid receptors. Trends Neurosci. 1988, 11: 308-314.
Lewis ME, Pert A, Pert CB, Herkenham M: Opiate receptor localization in rat cerebral cortex. J Comp Neurol. 1983, 216: 339-358.
Lewis ME, Khachaturian H, Watson SJ: Comparative distribution of opiate receptors and three opioid peptide neuronal systems in rhesus monkey central nervous system. Life Sci. 1983, 33 (Suppl 1): 239-242.
Zheng SX, Bosch MA, Ronnekleiv OK: mu-opioid receptor mRNA expression in identified hypothalamic neurons. J Comp Neurol. 2005, 487: 332-344.
Atweh SF, Kuhar MJ: Autoradiographic localization of opiate receptors in rat brain. III. The telencephalon. Brain Res. 1977, 134: 393-405.
Atweh SF, Kuhar MJ: Autoradiographic localization of opiate receptors in rat brain. II. The brain stem. Brain Res. 1977, 129: 1-12.
Atweh SF, Kuhar MJ: Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla. Brain Res. 1977, 124: 53-67.
Desjardins GC, Brawer JR, Beaudet A: Distribution of mu, delta, and kappa opioid receptors in the hypothalamus of the rat. Brain Res. 1990, 536: 114-123.
Ding YQ, Kaneko T, Nomura S, Mizuno N: Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. J Comp Neurol. 1996, 367: 375-402.
Goodman RR, Snyder SH, Kuhar MJ, Young WS: Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography. Proc Natl Acad Sci U S A. 1980, 77: 6239-6243.
McLean S, Rothman RB, Jacobson AE, Rice KC, Herkenham M: Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster. J Comp Neurol. 1987, 255: 497-510.
Jaferi A, Pickel VM: Mu-opioid and corticotropin-releasing-factor receptors show largely postsynaptic co-expression, and separate presynaptic distributions, in the mouse central amygdala and bed nucleus of the stria terminalis. Neuroscience. 2009, 159: 526-539.
Gutstein HB, Mansour A, Watson SJ, Akil H, Fields HL: Mu and kappa opioid receptors in periaqueductal gray and rostral ventromedial medulla. Neuroreport. 1998, 9: 1777-1781.
Wise SP, Herkenham M: Opiate receptor distribution in the cerebral cortex of the Rhesus monkey. Science. 1982, 218: 387-389.
Herkenham M, Pert CB: Light microscopic localization of brain opiate receptors: a general autoradiographic method which preserves tissue quality. J Neurosci. 1982, 2: 1129-1149.
de Gortari P, Mengod G: Dopamine D1, D2 and mu-opioid receptors are co-expressed with adenylyl cyclase 5 and phosphodiesterase 7B mRNAs in striatal rat cells. Brain Res. 2010, 1310: 37-45.
Jenck F, Quirion R, Wise RA: Opioid receptor subtypes associated with ventral tegmental facilitation and periaqueductal gray inhibition of feeding. Brain Res. 1987, 423: 39-44.
Jenck F, Gratton A, Wise RA: Opioid receptor subtypes associated with ventral tegmental facilitation of lateral hypothalamic brain stimulation reward. Brain Res. 1987, 423: 34-38.
Kuhar MJ, De Souza EB, Unnerstall JR: Neurotransmitter receptor mapping by autoradiography and other methods. Annu Rev Neurosci. 1986, 9: 27-59.
Herkenham M: Mismatches between neurotransmitter and receptor localizations in brain: observations and implications. Neuroscience. 1987, 23: 1-38.
Bernstein HG, Henning H, Seliger N, Baumann B, Bogerts B: Remarkable beta-endorphinergic innervation of human cerebral cortex as revealed by immunohistochemistry. Neurosci Lett. 1996, 215: 33-36.
McGregor A, Herbert J: The effects of beta-endorphin infusions into the amygdala on visual and olfactory sensory processing during sexual behaviour in the male rat. Neuroscience. 1992, 46: 173-179.
McGregor A, Herbert J: Specific effects of beta-endorphin infused into the amygdala on sexual behaviour in the male rat. Neuroscience. 1992, 46: 165-172.
Stavy M, Herbert J: Differential effects of beta-endorphin infused into the hypothalamic preoptic area at various phases of the male rat's sexual behaviour. Neuroscience. 1989, 30: 433-442.
Hughes AM, Everitt BJ, Herbert J: Selective effects of beta-endorphin infused into the hypothalamus, preoptic area and bed nucleus of the stria terminalis on the sexual and ingestive behaviour of male rats. Neuroscience. 1987, 23: 1063-1073.
Roth-Deri I, Green-Sadan T, Yadid G: Beta-endorphin and drug-induced reward and reinforcement. Prog Neurobiol. 2008, 86: 1-21.
Monteleone P: New frontiers in endocrinology of eating disorders. Curr Top Behav Neurosci. 2011, 6: 189-208.
Pecina S, Smith KS: Hedonic and motivational roles of opioids in food reward: implications for overeating disorders. Pharmacol Biochem Behav. 2010, 97: 34-46.
Kringelbach ML, Berridge KC: The functional neuroanatomy of pleasure and happiness. Discov Med. 2010, 9: 579-587.
Berridge KC, Ho CY, Richard JM, DiFeliceantonio AG: The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Res. 2010, 1350: 43-64.
Benton D: The plausibility of sugar addiction and its role in obesity and eating disorders. Clin Nutr. 2010, 29: 288-303.
Fulton S: Appetite and reward. Front Neuroendocrinol. 2010, 31: 85-103.
Gosnell BA, Levine AS: Reward systems and food intake: role of opioids. Int J Obes (Lond). 2009, 33 (Suppl 2): S54-S58.
Mahler SV, Berridge KC: Which cue to "want?" Central amygdala opioid activation enhances and focuses incentive salience on a prepotent reward cue. J Neurosci. 2009, 29: 6500-6513.
Nathan PJ, Bullmore ET: From taste hedonics to motivational drive: central mu-opioid receptors and binge-eating behaviour. Int J Neuropsychopharmacol. 2009, 12: 1-14.
Berridge KC: 'Liking' and 'wanting' food rewards: brain substrates and roles in eating disorders. Physiol Behav. 2009, 97: 537-550.
Reece AS: Hypothalamic opioid-melanocortin appetitive balance and addictive craving. Med Hypoth. 2011, 76: 132-137.
Bandelow B, Schmahl C, Falkai P, Wedekind D: Borderline personality disorder: a dysregulation of the endogenous opioid system?. Psychol Rev. 2010, 117: 623-636.
Riters LV: Evidence for opioid involvement in the motivation to sing. J Chem Neuroanat. 2010, 39: 141-150.
Camacho FJ, Portillo W, Quintero-Enriquez O, Paredes RG: Reward value of intromissions and morphine in male rats evaluated by conditioned place preference. Physiol Behav. 2009, 98: 602-607.
Pfaus JG: Pathways of sexual desire. J Sex Med. 2009, 6: 1506-1533.
Paredes RG: Evaluating the neurobiology of sexual reward. ILAR journal / National Research Council, Institute of Laboratory Animal Resources. 2009, 50: 15-27.
Nocjar C, Panksepp J: Prior morphine experience induces long-term increases in social interest and in appetitive behavior for natural reward. Behav Brain Res. 2007, 181: 191-199.
Kippin TE, van der Kooy D: Excitotoxic lesions of the tegmental pedunculopontine nucleus impair copulation in naive male rats and block the rewarding effects of copulation in experienced male rats. Eur J Neurosci. 2003, 18: 2581-2591.
Pitchers KK, Balfour ME, Lehman MN, Richtand NM, Yu L, Coolen LM: Neuroplasticity in the mesolimbic system induced by natural reward and subsequent reward abstinence. Biol Psychiatr. 2010, 67: 872-879.
Tenk CM, Wilson H, Zhang Q, Pitchers KK, Coolen LM: Sexual reward in male rats: effects of sexual experience on conditioned place preferences associated with ejaculation and intromissions. Horm Behav. 2009, 55: 93-97.
Olivier JD, de Jong TR, Jos Dederen P, van Oorschot R, Heeren D, Pattij T, Waldinger MD, Coolen LM, Cools AR, Olivier B, Veening JG: Effects of acute and chronic apomorphine on sex behavior and copulation-induced neural activation in the male rat. Eur J Pharmacol. 2007, 576: 61-76.
Coolen LM, Fitzgerald ME, Yu L, Lehman MN: Activation of mu opioid receptors in the medial preoptic area following copulation in male rats. Neuroscience. 2004, 124: 11-21.
Balfour ME, Yu L, Coolen LM: Sexual behavior and sex-associated environmental cues activate the mesolimbic system in male rats. Neuropsychopharmacology. 2004, 29: 718-730.
Nestler EJ: The neurobiology of cocaine addiction. Sci Pract Perspect. 2005, 3: 4-10.
Nestler EJ: Is there a common molecular pathway for addiction?. Nat Neurosci. 2005, 8: 1445-1449.
Di Chiara G, Imperato A: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A. 1988, 85: 5274-5278.
Spanagel R, Herz A, Shippenberg TS: Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens. Eur J Pharmacol. 1990, 190: 177-184.
Spanagel R, Herz A, Shippenberg TS: The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem. 1990, 55: 1734-1740.
Spanagel R, Weiss F: The dopamine hypothesis of reward: past and current status. Trends Neurosci. 1999, 22: 521-527.
Wilson CA, Hunter AJ: Progesterone stimulates sexual behaviour in female rats by increasing 5-HT activity on 5-HT2 receptors. Brain Res. 1985, 333: 223-229.
Schulze HG, Gorzalka BB: Low concentrations of oxytocin suppress lordosis when infused into the lateral ventricle of female rats. Endocr Regul. 1992, 26: 23-27.
Gorzalka BB, Heddema GM, Lester GL, Hanson LA: beta-endorphin inhibits and facilitates lordosis behaviour in rats depending on ventricular site of administration. Neuropeptides. 1997, 31: 517-521.
Gunther O, Kovacs GL, Szabo G, Telegdy G: Opposite effects of intraventricular and intracisternal administration of vasopressin on blood pressure in rats. Peptides. 1986, 7: 539-540.
Gunther O, Szabo G, Kovacs GL, Telegdy G: The effect on brain 5-HT of central lysine-vasopressin administration into different cerebral ventricular compartments depends on the site of injection. Neuropeptides. 1986, 7: 241-245.
O'Byrne KT, Eltringham L, Summerlee AJ: Central inhibitory effects of relaxin on the milk ejection reflex of the rat depends upon the site of injection into the cerebroventricular system. Brain Res. 1987, 405: 80-83.
Mumford AD, Parry LJ, Summerlee AJ: Lesion of the subfornical organ affects the haemotensive response to centrally administered relaxin in anaesthetized rats. J Endocrinol. 1989, 122: 747-755.
Skibicka KP, Grill HJ: Hypothalamic and hindbrain melanocortin receptors contribute to the feeding, thermogenic, and cardiovascular action of melanocortins. Endocrinology. 2009, 150: 5351-5361.
Skibicka KP, Grill HJ: Energetic responses are triggered by caudal brainstem melanocortin receptor stimulation and mediated by local sympathetic effector circuits. Endocrinology. 2008, 149: 3605-3616.
Zheng H, Corkern M, Stoyanova I, Patterson LM, Tian R, Berthoud HR: Peptides that regulate food intake: appetite-inducing accumbens manipulation activates hypothalamic orexin neurons and inhibits POMC neurons. Am J Physiol. 2003, 284: R1436-R1444.
Zheng H, Patterson LM, Phifer CB, Berthoud HR: Brain stem melanocortinergic modulation of meal size and identification of hypothalamic POMC projections. Am J Physiol. 2005, 289: R247-R258.
Zheng H, Patterson LM, Rhodes CJ, Louis GW, Skibicka KP, Grill HJ, Myers MG, Berthoud HR: A potential role for hypothalamomedullary POMC projections in leptin-induced suppression of food intake. Am J Physiol. 2010, 298: R720-R728.
Berthoud HR: A new role for leptin as a direct satiety signal from the stomach. Am J Physiol Regul Integr Comp Physiol. 2005, 288: R796-R797.
Berthoud HR, Sutton GM, Townsend RL, Patterson LM, Zheng H: Brainstem mechanisms integrating gut-derived satiety signals and descending forebrain information in the control of meal size. Physiol Behav. 2006, 89: 517-524.
Bach FW, Yaksh TL: Release of beta-endorphin immunoreactivity into ventriculo-cisternal perfusate by lumbar intrathecal capsaicin in the rat. Brain Res. 1995, 701: 192-200.
Bach FW, Chaplan SR, Jang J, Yaksh TL: Cerebrospinal fluid beta-endorphin in models of hyperalgesia in the rat. Regul Pept. 1995, 59: 79-86.
Strahlendorf JC, Strahlendorf HK, Barnes CD: Inhibition of periaqueductal gray neurons by the arcuate nucleus: partial mediation by an endorphin pathway. Exp Brain Res. 1982, 46: 462-466.
Skinner DC, Caraty A: Measurement and possible function of GnRH in cerebrospinal fluid in ewes. Reproduction. 2002, 59: 25-39.
Skinner DC, Caraty A, Malpaux B, Evans NP: Simultaneous measurement of gonadotropin-releasing hormone in the third ventricular cerebrospinal fluid and hypophyseal portal blood of the ewe. Endocrinology. 1997, 138: 4699-4704.